The comparison of antibody response to different hepatitis B vaccines with and without pre-S2 antigen in children with cancer

Pediatric Hematology and Oncology

Volumn 19, Issue 4, 2002, Pages 227-233

  Emir, Suna ^a   Büyükpamukçu, Münevver ^a   Akyüz, Canan ^a   Kutluk, Tezer ^a   Güler, Elif ^a   Çaǧlar, Kudret ^a  

^a NONE   (Turkey)

Author keywords

Cancer; Childhood; HBV vaccination; Pre S2 antigen

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPAVAX GENE; RECOMBINANT HEPATITIS B VACCINE; ENGERIX-B; GEN H B VAX; GEN-H-B-VAX; HEPATITIS B ANTIBODY; PRESURFACE PROTEIN 2, HEPATITIS B SURFACE ANTIGEN; PROTEIN PRECURSOR; RECOMBINANT VACCINE;

ADOLESCENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; CHILDHOOD CANCER; CHRONIC LIVER DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HIGH RISK PATIENT; HUMAN; IMMUNOGENICITY; INFANT; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; SEROCONVERSION; SOLID TUMOR; VACCINATION; BLOOD; COMPARATIVE STUDY; HEPATITIS B VIRUS; IMMUNIZATION; IMMUNOLOGY; NEOPLASM; PRESCHOOL CHILD; SEROLOGY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COMPARATIVE STUDY; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMAN; IMMUNIZATION; INFANT; LYMPHOMA; MALE; NEOPLASMS; PROTEIN PRECURSORS; SEROLOGIC TESTS; VACCINATION; VACCINES, SYNTHETIC; HUMANS;

EID: 0036014805     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/08880010252899389     Document Type: Article

References (23)

1. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy
2. Hepatitis B in an oncology unit
3. A therapeutic problem in pediatric oncology: The risk of HBs Ag positivity at the time of diagnosis
4. Hepatitis B virus infection in pediatric cancer patients receiving anti-cancer chemotherapy
5. Efficacy of immunization against hepatitis B virus infection in children with cancer
6. Impaired response to hepatitis B vaccine in children receiving anticancer chemotherapy
7. Hepatitis B vaccination and immune response in children with malignant diseases
8. Current update of pediatric hepatitis vaccine use
9. Immune response of immunocompromised children with malignancies to a recombinant hepatitis B vaccine
10. Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens in neonates
11. Immunogenicity of a recombinant pre-S2 containing hepatitis B vaccine versus plasma-derived vaccine administered as a booster
12. Recombinant DNA hepatitis B vaccine containing Pre-S components of the HBV coat protein: A preliminary study on immunogenicity
13. Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens in children
14. Immunogenicity of the recombinant GenHevac B Pasteur vaccine against hepatitis B in chronic uremic patients
15. Hepatitis B vaccination of hemodialysis patients: Randomized controlled trial comparing plasma-derived vaccine with and without pre-S2 antigen
16. Hepatitis B vaccination in children with acute lymphoblastic leukemia: Results of an intensified immunization schedule
17. Hepatitis B vaccination in children with thalassemia, hemophilia and cancer
18. Hepatitis B vaccination in children with cancer
19. Immunogenicity of hepatitis B vaccine in oncology patients receiving chemotherapy
20. Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines
21. Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen
22. Preliminary results of a randomized comparative immunogenicity study of three recombinant HBV vaccines in healthy medical personnel: Confirmation in man of the enhancement of anti-HBs response by pre-S2
23. Combined administration of hepatitis B vaccine and hepatitis B immune globulin in children with cancer